Recombinant Human IL-6 Protein, CF 206-IL-050/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human IL-6 Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $876.00Supplier Page View Company Product Page
Catalog Number206-IL-050/CF
Size50 ug (also 25 ug, 200 ug, 1 mg)
ApplicationsBioactivity
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS and NaCl
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight20.9 kDa
SpeciesHuman
Molecule NameIL-6
Source/Expression SystemE. coli-derived Recombinant Human IL-6 Protein, CF
NCBI Full Gene Nameinterleukin 6
NCBI Gene AliasesCDF, HSF, BSF-2, IL-6, IFNB2, HGF, BSF2, IFN-beta-2
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Circulating Immune Cell Signature Analysis in HFpEF Across SpeciesCirc ResAugust 15, 2025Jasmin Marga Kneuer, Marion Müller, Stephan Erbe, Karoline Elizabeth Kokot, Sebastian Rosch, Irina Müller-Kozarez, Sophie Charlotte Schröder, Christina Maeder, Sarah Felicitas Heitkamp, Susanne Gaul, et al.TNF-α (tumor necrosis factor alpha; 10 ng/mL; Peprotech, 300-01A), and IL-6 (10 ng/mL; R&D Systems, 206-IL-050/CF). For quantitative PCR (qPCR) and bulk RNA-seq, PBMCs were harvested after 4.5-hour cytokine treatment,

(2) Polarized Macrophages Show Diverse Pro-Angiogenic Characteristics Under Normo- and Hyperglycemic ConditionsInt J Mol SciMay 19, 2025Mahnaz Shariatzadeh, César Payán-Gómez, Julia Kzhyshkowska, Willem A. Dik, Pieter J. M. LeenenMiltenyi Biotec), M-CSF + IL-4 (40 ng/mL, # 130-093-917, Miltenyi Biotec), M-CSF + IL-6 (50 ng/mL, # 206-IL-050/CF, R&D Systems, Minneapolis, MN, USA), or M-CSF + IFN-γ (40 ng/mL, # 285-IF-100/CF, Bio-Techne, Minneapolis,

(3) Pan-cancer proteogenomics expands the landscape of therapeutic targetsCellAugust 8, 2024Sara R. Savage, Xinpei Yi, Jonathan T. Lei, Bo Wen, Hongwei Zhao, Yuxing Liao, Eric J. Jaehnig, Lauren K. Somes, Paul W. Shafer, Tobie D. Lee, et al.201-LB-025 IL-2,NCBI,Teceleukin (Ro 23-6019) IL-4,R&D Systems,Catalog: 204-IL/CF-MTO IL-6,R&D Systems,Catalog: 206-IL-050/CF IL-7,R&D Systems,Catalog: BT-007-01M IL-12,InvivoGen,Catalog: rcyc-hil12 IL-15,R&D Systems,Catalog:

(4) Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processingCytotherapyMarch 1, 2024Paul Shafer, Wingchi K. Leung, Mae Woods, Jong Min Choi, Carlos M. Rodriguez-Plata, Arushana Maknojia, Andres Mosquera, Lauren K. Somes, Jarrett Joubert, Anthony Manliguez, et al.U/mL), GM-CSF (800 U/mL), TNF-α (10 ng/mL) (R&D Systems, # 210TA100), IL-6 (100 ng/mL) (R&D Systems, # 206-IL-050/CF), IL-1β (10 ng/mL) (R&D Systems, # 201-LB-025), and PGE-2 (1 μg/mL) (Sigma, # P6532) and culturing at

(5) IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemiaEMBO molecular medicineJanuary 11, 2023Liu X, Sato N, Yabushita T, Li J, Jia Y, Tamura M, Asada S, Fujino T, Fukushima T, Yonezawa T, et al.

(6) IL-1 Generated by Oral Squamous Cell Carcinoma Stimulates Tumor-Induced and RANKL-Induced Osteoclastogenesis: A Possible Mechanism of Bone Resorption Induced by the Infiltration of Oral Squamous Cell CarcinomaInternational journal of molecular sciencesDecember 30, 2022Fukawa Y, Kayamori K, Tsuchiya M, Ikeda T.

(7) Susceptibilities of CNS Cells towards Rabies Virus Infection Is Linked to Cellular Innate Immune ResponsesVirusesDecember 29, 2022Feige L, Kozaki T, Dias de Melo G, Guillemot V, Larrous F, Ginhoux F, Bourhy H.

(8) Gene Expression Linked to Reepithelialization of Human Skin WoundsInternational journal of molecular sciencesDecember 12, 2022Ågren MS, Litman T, Eriksen JO, Schjerling P, Bzorek M, Gjerdrum LMR.

(9) A portable analog front-end system for label-free sensing of proteins using nanowell array impedance sensorsScientific reportsNovember 22, 2022Tayyab M, Xie P, Sami MA, Raji H, Lin Z, Meng Z, Mahmoodi SR, Javanmard M.

(10) Improved Sendai viral system for reprogramming to naive pluripotencyCell Rep MethodsNovember 21, 2022Kunitomi A, Hirohata R, Arreola V, Osawa M, Kato TM, Nomura M, Kawaguchi J, Hara H, Kusano K, Takashima Y, et al.

(11) Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAKNature communicationsOctober 8, 2022Ge C, Tan J, Dai X, Kuang Q, Zhong S, Lai L, Yi C, Sun Y, Luo J, Zhang C, et al.(055:B5); Cat#L2880) were purchased from Sigma–Aldrich (St. Louis, USA). Recombinant human IL-6 (Cat#206-IL-050/CF), TNF-α (Cat#210-TA-020/CF), and TGF-β1 (Cat#240-B-002) proteins were purchased from R&D system (Minneapolis,

(12) DLL4 and VCAM1 enhance the emergence of T cell-competent hematopoietic progenitors from human pluripotent stem cellsScience advancesAugust 26, 2022Michaels YS, Edgar JM, Major MC, Castle EL, Zimmerman C, Yin T, Hagner A, Lau C, Hsu HH, Ibañez-Rios MI, et al.

(13) Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 ReceptorCellsAugust 19, 2022Rode AKO, Buus TB, Mraz V, Al-Jaberi FAH, Lopez DV, Ford SL, Hennen S, Eliasen IP, Klewe IV, Gharehdaghi L, et al.

(14) Identification of a distal enhancer that determines the expression pattern of acute phase marker C-reactive proteinThe Journal of biological chemistryAugust 1, 2022Wang MY, Zhang CM, Zhou HH, Ge ZB, Su CC, Lou ZH, Zhang XY, Xu TT, Li SY, Zhu L, et al.

(15) SH2D4A downregulation due to loss of chromosome 8p is associated with poor prognosis and low T cell infiltration in colorectal cancerBritish journal of cancerApril 1, 2022Matsumoto T, Okayama H, Nakajima S, Saito K, Ito M, Kaneta A, Kanke Y, Onozawa H, Hayase S, Fujita S, et al.

(16) Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathwayScientific reportsMarch 22, 2022Dritsoula A, Dowsett L, Pilotti C, O'Connor MN, Moss SE, Greenwood J.

(17) The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma CellsCancersMarch 11, 2022Sekhri P, Ledezma DK, Shukla A, Sweeney EE, Fernandes R.

(18) Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survivalScience advancesFebruary 25, 2022Whitburn J, Rao SR, Morris EV, Tabata S, Hirayama A, Soga T, Edwards JR, Kaya Z, Palmer C, Hamdy FC, et al.

(19) Modeling In Vitro Osteoarthritis Phenotypes in a Vascularized Bone Model Based on a Bone-Marrow Derived Mesenchymal Cell Line and Endothelial CellsInternational journal of molecular sciencesSeptember 3, 2021Pirosa A, Tankus EB, Mainardi A, Occhetta P, Dönges L, Baum C, Rasponi M, Martin I, Barbero A.

(20) IL-27 Mediates PD-L1 Expression and Release by Human Mesothelioma CellsCancersAugust 9, 2021Carbotti G, Dozin B, Martini S, Giordano C, Scordamaglia F, Croce M, Filaci G, Ferrini S, Fabbi M.

Be the First to Write a Review!

Recombinant Human IL-6 Protein, CF

IL-6 Protein

IL-6 Protein

IL-6 Protein

Recombinant Human IL-6 Protein, CF from R&D Systems, a Bio-Techne Brand

Description

R&D Systems, a Bio-Techne Brand

Citations (361)

Reviews

Recombinant Human IL-6 Protein, CF from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map